NORMAL CELLS HAVE A LIMITED lifespan in which they cease to proliferate after a finite number of population doublings (55) . Replicative senescence is achieved when the cells enter the irreversible growth arrest phase (G 0 /G 1 arrest) of the cell cycle (40) . Senescent cells do not divide but remain viable and metabolically active. These cells have enlarged and flattened morphology, increased granularity and vacuolization, altered expressions of genes and proteins, and shortened telomere length; they characteristically express senescence-associated ␤-galactosidase (SA-␤-gal) activity at pH 6.0 (22) . Besides replicative senescence, numerous factors can contribute to stress-induced premature senescence. They include exposure to sublethal dose of DNA damaging agents (e.g., certain anticancer drugs), gamma irradiation, oxidative stress, overexpression of activated oncogenic Ras (or of its downstream effectors such as Raf), activation of tumor suppressor genes (e.g., p53, p16, and pRB), deprivation of nutrients or growth factors, and improper cell contacts (4, 12) .
MicroRNAs (miRNAs) are a well-recognized group of short (Ϸ22 nt), noncoding RNAs (27) . Currently, the miRNA database [Sanger miRBase (http://www.mirbase. org/)] lists Ͼ18,000 entries. miRNAs regulate gene expression by targeting 3=-untranslated region (UTR) of mRNA transcripts that in turn results in translational inhibition or degradation of mRNA. The majority of miRNAs repress gene expression, but a minority group activates it by upregulating translation (39, 54) . Unique alterations in miRNA expression contribute to the regulation and induction of diseases such as various types of cancers, diabetes, and autoimmune diseases (31) . In particular, the miRNA profile is altered in heart disease, and the pattern of miRNA expression is distinct in different forms of cardiac disorders (19) . A unique miRNA signature is associated with the involvement of specific signal transduction pathway and thus with the prognosis and pathogenesis of the disease. For instance, miRNA (miR)-21 contributes to myocardial disease by stimulating MAP kinase signaling in fibroblasts, and miR-126 accelerates the development of atherosclerosis (3, 51) . In addition, overexpression of miR-34a induces cell cycle arrest and senescence in human umbilical vein endothelial cells (HUVECs), an effect mediated by the SIRT1-p53 pathway (59) .
Endothelial cells are specialized cells that line the vascular lumen. They play an important role in modulating vascular tone, exchanges of molecules between blood and tissues, prevention of coagulation, and formation of new blood vessels. Senescent endothelial cells contribute to age-related vascular disorders such as atherosclerosis and cardiovascular diseases (36) . Alterations in miRNA expression have been reported in senescent endothelial cells, suggesting that miRNAs play roles in the regulation of senescence in these cells (35, 53) . HUVECs have been widely used in numerous in vitro studies on human endothelial cells. Despite discrepancies noted between HUVECs and the different parts of vasculature, they do share many common functional and morphological features (50, 53) . Hence, results obtained from HUVECs will provide preliminary observations leading to subsequent physiologically relevant in depth investigations.
In earlier studies in senescent HUVECs, miRNA and gene expression profiling have been performed independently, making direct identification of miRNA target genes challenging (7, 23, 35, 40, 47) . The present study, hence, was designed to perform an integrated study of miRNA and gene expression in HUVECs, in the hope to provide new insights into the role of miRNAs in cellular senescence and age-related disorders and to define their potential as diagnostic markers and/or therapeutic targets.
MATERIALS AND METHODS
Cell culture. HUVECs were purchased from ScienCell Research Laboratories (Carlsbad, CA) and maintained in endothelial cell medium (ECM) supplemented with 5% FBS, 1% endothelial cell growth supplement, and 1% of penicillin-streptomycin (ScienCell Research Laboratories) at 37°C in a humidified atmosphere of 95% air/5% CO 2. The number of population doublings (PD) was calculated as described (8, 25) Cells were seeded at a constant initial density of 5 ϫ 10 5 cells per T75 flask and passaged with 0.25% trypsin EDTA every 2-3 days to maintain the cultures in constant log phase. Replicative senescent cells were obtained by consecutively passaging the young cells until the cells proliferation became nearly arrested, approximately at passage 25 (PD ϳ45).
Young and senescent cells used in experiments are cells with PD Ͻ 10 and PD Ͼ 45, respectively, unless otherwise mentioned. Morphological changes were monitored and evaluated for every subculture. The images of young and senescent cells were captured, examined and recorded with light microscopy at a magnification of ϫ200.
SA-␤-gal. Cells were stained using a SA-␤-gal staining kit (Cell Signaling Technology, Beverly, MA) following the manufacturer's instructions. In brief, cells were washed once in one time (1ϫ) PBS, fixed for 15 min in 1ϫ fixative solution, washed twice in 1ϫ PBS before being incubated in fresh SA-␤-gal staining solution at 37°C overnight. The percentage of positively stained cell (blue cells) versus total cells was counted by randomly choosing 10 microscopic fields under ϫ20 objective magnification.
MTT cell viability assay. Briefly, cells were seeded in 96-well plates at optimum cell density. After 18 -24 h, cells were transfected with 31.25, 62.5, 125, 250, and 500 nM of miRIDIAN hairpin inhibitor of hsa-miR-299-3p (A299-3p) (Dharmacon, Lafayette, CO) for 24 h. Control wells were transfected with equal concentrations of control antisense oligonucleotide (C A) i.e., miRIDIAN hairpin inhibitor negative control #2 (Dharmacon). Following transfection, cells were incubated in the dark with 2 mg/ml MTT at 37°C for 2 h, then the medium was carefully removed, and 100 l of DMSO was added to dissolve the formazan crystals formed. Absorbance was measured at 570 nm in a plate reader. Cell viability was calculated by the following formula: (mean absorbance in test wells)/(mean absorbance in control well) ϫ 100%.
Hydrogen peroxide study. Hydrogen peroxide (H 2O2, BDH AnalaR) was used to induce premature senescence. In brief, young cells were seeded at optimum cell density and incubated overnight. The cells were subjected to two successive sublethal treatments of 200 M H 2O2 in ECM containing 5% FBS for 2 h, with one treatment per day for 2 consecutive days. At the end of each treatment, the treatment media were removed and the cells were washed twice with 1ϫ PBS and maintained in ECM with 5% FBS.
Real-time growth profile. Cells were seeded in a 16-well E-plate, and the growth kinetic of the cells was monitored continuously using a Roche xCELLigence Real Time Cell Analyzer (RTCA; Roche Diagnostic, Mannheim, Germany) DP instrument at 37°C in a humidified atmosphere of 95% air/5% CO 2. The xCELLigence system utilizes E-plate (Roche Diagnostic), which contains interdigitated microelectrodes on the bottom of the plate that detect local ionic changes as cells proliferate, and the proliferation rate is measured as electrode impedance. Cell sensor impedance was expressed as an arbitrary unit termed cell index (CI). The CI at each time point was defined as (R n Ϫ Rb)/15, where Rn is the cell electrode impedance of the well and the Rb is the background impedance of the well with the media alone.
Telomere length measurement. Relative telomere (T) length was measured by a modified quantitative real-time polymerase chain reaction (qRT-PCR) method (6) . Genomic DNAs were extracted from cells using QIAmp DNA blood mini kit (Qiagen, Hilden, Germany) in accordance with the manufacturer's protocol. Telomeric hexamer repeats were quantitated using T and single copy gene (S) PCR. T and S PCR were performed using Power SYBR green PCR master mix (Applied Biosystems, Foster, CA) on ABI StepOne system. T and ␤-globin primer pairs (primer sequences shown below) were used for T and S PCR, respectively: telg, ACACTAAGGTTTGGGTTTGGGTTTGGGTTTGGGT-TAGTGT; telc, TGTTAGGTATCCCTATCCCTATCCCTATC-CCTATCCCTAACA; hbgu, CGGCGGCGGGCGGCGCGGGCT-GGGCGGCTTCATCCACGTTCACCTTG; hbgd, GCCCGGCCCGC-CGCGCCCGTCCCGCCGGAGGAGAAGTCTGCCGTT.
The thermal cycling profile for both T and S PCR was as follows: 12 .0, and 19,596 human genes were performed using Agilent Human MicroRNAs and Whole Human Genome microarray platforms, respectively. Total RNAs were isolated from cells using miRNeasy mini kit (Qiagen) according to manufacturer's protocol. RNA integrity of the total RNA was accessed using Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). For miRNA microarrays, total RNAs (100 ng) were labeled with Cyanine 3-pCp and hybridized onto Human MicroRNA Array version 3.0 (8X15K) with 40 -60 mer oligonucleotides probe spotted on the slide by SurePrint Inkjet technology (Agilent Technologies). For gene expression microarrays, cRNA was synthesized from 50 ng of total RNAs, labeled with Cyanine 3-CTP, and hybridized onto Whole Human Genome Array (4 ϫ 44k), which was spotted by the 60-mer SurePrint technology (Agilent Technologies). The microarray slides were scanned on microarray Scanner B, and data were extracted with Feature Extraction software (Agilent Technologies). Microarray data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO series accession no. GSE37093.
Microarray data analysis. Integrated analysis of microRNA and gene expression microarray data was performed using GeneSpring GX version 11.05 (Agilent Technologies). The threshold of raw signals was set at 1.0. The normalization algorithm employed was quantile, and baseline transformation to median of all samples was performed. Differential miRNA and gene expression profiles of young vs. senescent cells were generated with Volcano Plot in GeneSpring GX, which consists of the significance analysis and fold change filter. Significance analysis was performed by Student's t-test for unpaired observations with asymptotic corrected P value Ͻ 0.05 and fold change filter of Ͼ 2.0. The multiple testing correction employed was Benjamini-Hochberg. The TargetScan program integrated in GeneSpring was used to identify the biological targets of the differentially expressed miRNAs. In addition, homology regions between miRNAs of interest and 3=-UTR of the target gene of interest were identified with miRanda (http://www.microrna.org/microrna/home.do). The miRNA profile was then translated to the gene expression data. The joint miRNA and gene expression profile was then subjected to pathway analysis. The pathway map generated from pathway analysis was analyzed to select miRNAs of interest. The miRNAs of interest reported have not been previously associated with cellular senescence but showed association with known cellular senescence-associated genes in the pathway maps.
qRT-PCR validation of miRNA and gene expression. Two-step qRT-PCR was performed to quantitatively measure the expression of miRNA and gene to validate the microarray data. For validation of miRNA expression, cDNA was synthesized from 10 ng of total RNA using a Taqman microRNA Reverse Transcription Kit according to manufacturer's protocol (Applied Biosystems). qRT-PCR was performed using Taqman MicroRNA Assay and Taqman Universal PCR Master Mix (Applied Biosystems). Taqman MicroRNA Assay ID are as follows: hsa-miR-130b (assay ID: 000456), hsa-miR-18b (assay ID: 002217), hsa-miR-299-3p (assay ID: 001015), hsa-miR-338-3p (assay ID: 002252), hsa-miR-134 (assay ID: 001186), hsa-miR-17 (assay ID: 002308), hsa-miR-188-5p (assay ID: 002320), RNU6B (control miRNA assay) (assay ID: 001093). RNU6B (human) was used as endogenous reference RNA for normalization of data. For validation of gene expression, cDNA was synthesized from 250 ng total RNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) according to the manufacturer's protocol. qRT-PCR was performed using Taqman Gene Expression Assay and Taqman Fast Advanced PCR Master Mix. Taqman Gene Expression assay ID are as follow: IGF1 (assay ID: Hs_01547656_m1), SLFN13 (assay ID: Hs_00431187_m1), HDAC9 (assay ID: Hs_00206843_m1). GAPDH (assay ID: 4333764F) was used as endogenous reference RNA for normalization of data. Analysis was performed by the 2
Ϫ⌬⌬Ct method. miRNA knockdown study. Transfection of HUVECs was performed using DharmaFECT 1 according to the manufacturer's instructions (Dharmacon). In brief, cells were seeded in growth medium without antibiotics at a density of 10,000 cells per well and incubated overnight. The cells were then transfected with 7.8, 15.6, 31.25, 62.5, 125, 250 and 500 nM of A299-3p (Dharmacon) for 24 h. After the knockdown of miRNA, Taqman MicroRNA Assay was performed as described above to measure the expression of hsa-miR-299-3p. The expression of hsa-miR-299-3p was compared with growth medium control.
For mRNA expression measurement, the cells were transfected with 31.25, 62.5, 125, 250, and 500 nM of A299-3p (Dharmacon) for 24 h. Control wells were transfected with equal concentrations of C A, i.e., miRIDIAN hairpin inhibitor negative control #2 (Dharmacon). After the knockdown of miRNA, Taqman Gene Expression Assay was performed as described above to measure the expression of IGF1 mRNA.
For SA-␤-gal staining, real-time growth profile and cell migration assay, the cells were transfected with 31.25, 62.5, 125, 250, and 500 nM of A299-3p (Dharmacon) for 48 h. Control wells were transfected with equal concentrations of C A i.e., miRIDIAN hairpin inhibitor negative control #2 (Dharmacon). SA-␤-gal staining, real-time growth study, cell cycle analysis, and cell migration assay were performed to determine the percentage of SA-␤-gal positively stained cells, growth and migration capacity after transfection.
For concurrent knockdown of multiple miRNAs, cells were transfected with a total concentration of 31.25, 62.5, 125, 250, and 500 nM of combination of miRIDIAN miRNA hairpin inhibitor for hsa-miR-134, -299-3p, and -338-3p. Control wells were transfected with equal http://physiolgenomics.physiology.org/ concentrations of CA, i.e., miRIDIAN hairpin inhibitor negative control #2 (Dharmacon). Total RNA were harvested after transfection, and Taqman Gene Expression Assay was performed as described above to check the expression of IGF1 mRNA.
Cell migration assay. Cell migration assay was performed with CIM plates (Roche Diagnostic) according to the standard protocol suggested by the manufacturer. In brief, after 48 h transfection, cells were starved using 0.5% FBS containing growth media for 5 h. Following starvation, they were trypsinized and seeded onto upper chamber of CIM plates at cell density of 14,000 cells per well. The lower chamber of CIM plates were filled up with 10% FBS containing growth media acting as chemoattractant. The CIM plates were loaded onto RTCA DP instrument (Roche Diagnostic) to monitor real-time cell migration. Microelectronic sensors are integrated onto the underside of the microporous polyethylene terephthalate membrane of the CIM plate (Boyden-like chamber). Cells migrate from the upper chamber through the membrane into the bottom chamber, contact, and adhere to the electronic sensors on the underside of the membrane and alter impedance. Cell sensor impedance was expressed as CI.
Statistical analysis. All data are presented as means Ϯ SE. Statistical analysis was performed with Student's t-test using GraphPad Prism software (version 5.0; GraphPad Software, San Diego, CA). P values Ͻ 0.05 were accepted to indicate statistically significant differences. Statistical significance is expressed as ***P Ͻ 0.001, **P Ͻ 0.01, *P Ͻ 0.05.
RESULTS
Characterization of replicative senescence. Replicative senescence (RS) was confirmed in HUVECs with Ͼ45 PD by the following observations: 1) RS cells were relatively enlarged and flattened and showed an increase in granulation and vacuolization compared with their younger counterpart (Fig. 1A) ; 2) RS showed a significant increase (ϳ60%) in the percentage of SA-␤-gal-positive cells compared with young cells (Fig. 1 , B and C); 3) the real-time growth kinetics of RS showed a relatively lower CI and remained viable in culture over a long period of time, while young cells showed a relatively higher CI and were eventually eliminated from the culture (Fig. 1D) ; 4) cell cycle analysis revealed that RS cells had a significant increase in G 0 /G 1 population (ϳ40%) compared with the young cells, suggesting that RS cells stopped proliferation through G 0 /G 1 arrest in the cell cycle (Fig. 1E) ; and 5) the T length of RS cells was also shorter compared with the young cells (Fig. 1F) .
miRNA and gene expression profile. The comparison of the miRNA profile in young and RS cells showed that 29 miRNAs were expressed differentially in the latter, including upregulation of 19 miRNAs and downregulation of 10 others (Table 1 ). In the gene expression analysis, 251 genes were differentially regulated in RS, with 130 down-and 121 upregulations ( Fig. 2A) . Microarray datasets are available for viewing at GEO through accession no. GSE37093. To validate the microarray findings, we performed qRT-PCR for seven miRNAs. Overall, the qRT-PCR analysis showed satisfactory correlation with the microarray results, although smaller fold-changes were found by qRT-PCR (Fig. 3A) . In particular, the qRT-PCR results showed that hsa-miR-130b, -18b, and -17 were downregulated, while hsa-miR-299-3p, -338-3p, -134, and -188-5p were upregulated in RS compared with young cells (Fig. 3A) . Computational simulation of biological interactions of differentially expressed target genes of hsa-miR-299-3p in senescent HUVECs were also identified (Fig. 2C) . In additional, TargetScan analysis suggested that IGF1 is a target of hsa-miR-299-3p, -134, and -338-3p. Homology region between hsa-miR-299-3p and 3=-UTR of IGF1 was also identified by miRanda, where the score of homology match (mirSVR score) was Ϫ0.4165 [ Fig.  2B(i) ]. miRNA targets with mirSVR score ϽϪ0.1 is considered as "good," and miRNA targets with ϾϪ0.1 mirSVR score indicates "nongood" (46) . This further confirmed the potential regulation of IGF1 by hsa-miR-299-3p. Prior to subsequent knockdown studies, the inherent mRNA expression of IGF1 was measured. The qRT-PCR results showed that IGF1 was upregulated by approximately sevenfold in RS compared with young cells (Fig. 3B) .
IGF1 as potential target of hsa-miR-299-3p. hsa-miR-299-3p was knocked down transiently in RS cells by transfection with a range of concentrations (7.8 -500 nM) of A299-3p or C A . Target gene expression, percentage of SA-␤-gal positive, cell growth, and migration were determined after the knockdown. Transfection with the hsa-miR-299-3p inhibitor A299-3p resulted in a significant concentration-dependent knockdown, ranging from a 45% (7.8 nM) to 85% (500 nM) decrease in the expression of hsa-miR-299-3p as quantified by qRT-PCR (Fig. 3C) .
To investigate if hsa-miR-299-3p targets IGF1, we measured the mRNA expression level of IGF1 following the knockdown of hsa-miR-299-3p. Transient inhibition of hsa-miR-299-3p resulted in a dose-dependent increase in the mRNA expression of IGF1, with the level significantly surpassing that of the antisense oligonucleotide at 250 nM ( Fig. 4A , P Ͻ 0.01) by ϳ30% compared with the C A . Since the knockdown was performed on near-arrested cells at passage 25 (PD ϳ45), the true effect of hsa-miR-299-3p inhibition may not be apparent.
Hence, we used cells that are at the presenescence stage at cell passage 19 for subsequent hsa-miR-299-3p knockdown. In passage 19 cells, knockdown of hsa-miR-299-3p resulted in a dose-dependent (except at 500 nM) increase in the mRNA Fold-change cut-off: 2.0. P value computation by Student t-test. Multiple testing correction: Benjamini-Hochberg false discovery rate; Corrected P value cut-off: 0.05. B: homology region between hsa-miR-299-3p, -134, -338-3p, and 3=-untranslated region of IGF1 mRNA sequence. C: computational simulation of biological interactions of differentially expressed target genes of hsa-miR-299-3p in senescent HUVECs as revealed by GeneSpring GX version 11.5.1 Pathway Analysis. IGF-1 is boxed in red. expression of IGF1 (Fig. 4B) . A significant increase was observed at many concentrations of A299-3p (62.5 nM onward). Hence, this result shows that knockdown of hsa-miR-299-3p affects IGF1 mRNA expression.
Because TargetScan analysis identified that hsa-miR-134 and -338-3p also target IGF1, we hypothesize that knockdown of hsa-miR-299-3p in combination with hsa-miR-134 and -338-3p may enhance the elevation in IGF1 mRNA expression. Knockdown of hsa-miR-299-3p in combination with hsa-miR-134 and -338-3p resulted in a significant increase in the mRNA expression of IGF1 compared with the C A . Concurrent inhibition of hsa-miR-134, -299-3p, and -338-3p at 31.25 and 62.5 nM resulted in ϳ130 and ϳ170% increase in the mRNA expression of IGF1, respectively ( Fig. 4C ; P Ͻ 0.01 and P Ͻ 0.05, Student's t-test). These data show that knockdown of hsa-miR-299-3p together with other miRNAs that target IGF1 can release the suppression of IGF1 with greater efficacy at low concentrations of the inhibitors used.
Inhibition of hsa-miR-299-3p and replicative senescence. To further confirm the role of hsa-miR-299-3p in modulating senescence, SA-␤-gal pH 6.0 staining, MTT cell viability assay, real-time growth studies, and cell migration assay were performed after inhibition of hsa-miR-299-3p at a range of concentration of the hsa-miR-299-3p inhibitor, A299-3p. A significant dose-dependent decrease in the percentage of SA-␤-gal-positive cells was observed at all concentrations of inhibition of hsa-miR-299-3p compared with C A except for 500 nM (Fig. 5, A and B hsa-miR-299-3p (Fig. 5B) , while the lowest reduction in percentage of SA-␤-gal-positive cells (reduced from ϳ40 to 30%) was observed at 500 nM of inhibition of hsa-miR-299-3p, which did not reach statistical significance (Fig. 5B) . Cell viability as measured by MTT assay also showed a significant dose-dependent increase in cell viability following the inhibition of hsa-miR-299-3p at all tested concentrations compared with C A except for 500 nM (Fig. 5C ). Real-time growth kinetics of RS cells was examined following knockdown of hsa-miR-299-3p (Fig. 6, A-E) . Normalized CI of RS cells increased after knockdown of hsa-miR-299-3p, particularly at 250 nM (Fig. 6D ) and 500 nM (Fig. 6E) , though this did not reach statistical significance. This suggests that knockdown of hsa-miR-299-3p marginally improved the proliferative capacity of RS cells. Since knockdown of hsa-miR-299-3p could only marginally improve the proliferative capacity of RS cells, we investigated whether knockdown of hsa-miR-299-3p could protect cells from H 2 O 2 -induced senescence by treating the cells with H 2 O 2 followed by transfection with hsa-miR-299-3p inhibitor A299-3p. Real-time growth kinetics analysis showed that transfection with 62.5 and 125 nM of hsa-miR-299-3p inhibitor A299-3p resulted in significant increase in the proliferation of the transfected cells compared with those transfected with negative control inhibitor, C A (Fig. 7 , B and C; P Ͻ 0.01 and P Ͻ 0.05, Student's t-test). This finding suggests that inhibition of hsa-miR-299-3p can overcome H 2 O 2 -induced senescence and stimulate the proliferation of the senescing cells.
To evaluate the role of hsa-miR-299-3p in modulating cell migration of RS cells, we performed cell migration assay following knockdown of hsa-miR-299-3p (Fig. 8, A-E) . The CI of RS cells increased at 62.5 nM (Fig. 8B) and 125 nM (Fig.  8C ) of A299-3p, though not statistically significantly. This indicates that knockdown of hsa-miR-299-3p at 62.5 and 125 nM slightly increases the cell migration capacity of RS cells.
DISCUSSION
The involvement of several miRNAs is established in the regulation of replicative senescence. These include hsa-miR146a [targeting NOX4 (53) ], hsa-miR-34a [acting on the SIRT1-p53 pathway (59)], and hsa-miR-17 [targeting the cdk inhibitor p21/CDKN1A (15)]. Because of the rapid expansion of the field of miRNAs and the complexity of the interaction of individual miRNAs with targeting several genes, there is a need to delineate the role of specific miRNAs in replicative senescence. Hence, in the present study we undertook an integrated profiling analysis of miRNAs and genes in senescent HUVECs to identify other potential senescence-associated miRNAs. Changes in gene expression profiles associated with senescence have been reported in several cell types (12, 32, 41, 47) . In the present study, integrative analysis of miRNA and gene expression profiling of RS in HUVECs suggests that 29 miRNAs in RS may regulate at least 251 genes. In particular, the miRNA profiling results reveal that hsa-miR-299-3p is upregulated in RS HUVECs, and TargetScan analysis on gene http://physiolgenomics.physiology.org/ expression profiles derived from the same RNA samples shows that one of its potential targets is IGF1. Other highly deregulated miRNAs shown in the miRNA profile were not chosen for further investigation because these have been reported for their association with senescence. For instance, Watanabe et al.
showed that hsa-miR-150 induce senescence in NK/T-cell lymphoma lines (57) . hsa-miR-146a was reported to modulate endothelial cell aging via NOX4. (53) . hsa-miR-299-3p was chosen for further investigation due to its relevant target gene i.e., IGF1, which was reported to be highly associated with senescence or cell proliferation and growth.
To evaluate the effect of inhibition of hsa-miR-299-3p on replicative senescence, we used an SA-␤-gal assay. SA-␤-gal activity has been widely used as biomarker of senescence in vitro and in vivo since its first description by Dimri et al. (10) . It has been described as the "gold standard" marker for cellular senescence, despite the fact that its function and origin remained unknown (9, 14, 38, 56) . Studies have shown that the increase in SA-␤-gal activity in cellular senescence reflects an increase in lysosomal mass in senescent cells and that SA-␤-gal is not required for senescence (24, 26) . The MTT assay is commonly used to screen compounds for effects on viability, and reduction of MTT to formazan is due to cellular enzymatic activity in mitochondria, endosomes, and lysosomes (5, 30) . Factors in the cell culture environment such as pH and glucose, NADH, or NADPH supply also influence MTT reduction to formazan (17, 34) , and thus MTT data also reflect changes in cell metabolism. Knockdown of hsa-miR-299-3p reduced the percentage of SA-␤-gal-positive cells in the senesced culture and increased cell viability as measured with MTT assay, but the real-time growth kinetics data did not show a significant increase in cell proliferation. As both SA-␤-gal and MTT assay are dependent on cellular enzymatic activities that are reflective of cell metabolism, it is suggestive that knockdown of hsa-miR-299-3p may have improved the metabolic activity of the senescent cells, without stimulating cell proliferation and increase cell numbers. Cell cycle analysis supports this observation as inhibition of hsa-miR-299-3p did not stimulate the G 0 /G 1 population to reenter the cell cycle (data not shown). mRNA expression of IGF1 that was upregulated in RS HUVECs but not in their young counterpart was also elevated following the inhibition of hsa-miR-299-3p in senescent and presenescent HUVECs. Moreover, in presenescent cells, a dose-dependent increase in IGF-1 expression was observed at low concentrations of anti-miR used, suggesting that hsa-miR-299-3p may, in part, mediate its actions through IGF1. In addition, knockdown in combination with two other miRNAs, i.e., hsa-miR-134 and -338-3p, that target IGF-1 further increased the elevation of IGF1 mRNA expression at low concentrations of anti-miR used. IGF1 signaling has been described as an evolutionarily conserved mechanism of longevity in nematodes, fruit flies, yeast, rodents, and humans (2). However, a recent contrasting review suggests that IGF1 signaling is not part of an evolutionarily conserved mechanism of longevity in humans. Human lifespan does not increase correspondingly with a decline in IGF1 signaling, contrary to evidence found in nematodes, fruit flies, and rodents (reviewed in Ref. 49 ). IGF1 plays an essential role in stimulating DNA synthesis, amino acid uptake, protein synthesis, and glucose transport in various cells (2) . It also acts as a growth factor in many tissues and tumors (1) . Excess of IGF1 predispose humans to risk of neoplastic diseases (49) . In contrast, IGF1 deficiency increases the risk for cardiovascular complications in aged individuals, particularly atherosclerosis (18, 52) . Despite the fact that IGF1 has been largely associated with aging, the molecular mechanism underlying its action remains controversial. Senescent cells do not respond to IGF1 (in combination with other growth factors) with DNA synthesis and mitosis, despite possessing a number of IGF1 receptors comparable to that of young cells (45) . Treatment with IGF1 extends longevity in a mouse model of premature aging by restoring somatotrophic function (33) , and localized IGF1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle (37) . There is limited information on the role of miRNAs in modulating IGF1 and in turn regulating senescence. Thus far, it is only reported that miR-71 and miR-239 promote longevity of Caenorhabditis elegans via the insulin/IGF-1-like pathway (42) . In addition, the findings of the present study indicate the potential of hsa-miR-299-3p in modulating IGF1 and thus regulating senescence.
In terms of cell migration, although in general we do not see a significant improvement in cell migration following hsa-miR-299-3p knockdown, the knockdown improved migration capacity. Previous reports demonstrate that IGF1 stimulated endothelial cell migration (20, 29, 48) . Those findings support the suggestion that cell migration improvement is due to the optimal IGF1 expression modulated by hsa-miR-299-3p.
miRNA expression profiles have been demonstrated to be highly tissue, organ, disease, or developmental stage specific. Numerous studies have been performed to investigate the age-related alteration of miRNA signature in various tissues or organs, aimed at identifying a unique miRNA signature that could be useful for the development of tissue-or organ-specific biomarkers, as well as therapeutic strategies for age-related complications (13, 28, 31, 43, 44, 58) . The miRNA signature obtained in the present study is in agreement with findings from earlier studies. For instance, hsa-miR-134 (senescent fibroblast) (11), hsa-miR-17 (senescent human diploid fibroblast, HUVEC, renal proximal tubular epithelial cells, T-cells, bone marrow derived mesenchymal stem cells, human foreskin) (15) , and hsa-miR-146a (senescent HUVEC) (53) were found to be differentially expressed in RS HUVECs in the present study. The similarities suggest that those miRNAs are potential biomarker of cellular senescence due to the high reproducibility across various independent studies. Furthermore, the similarities strengthen the reliability of current findings. On the other hand, differences in miRNA expression profile between the current study and previous studies were also noticed. hsa-miR-217 (35) and -34a (21) , which were found to be differentially expressed in senescent HUVECs, were not present in the current study. The discrepancies found are most likely due to the HUVECs, which originate from In summary, the present study reveals that hsa-miR-299-3p plays a role in cellular senescence in HUVECs. Its ability to delay premature senescence is mediated, at least in part, through IGF1. Further investigations are necessary to confirm its role in IGF1 signaling and to determine whether and how hsa-miR-299-3p acts in tandem with other miRNAs identified by the present experiments.
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